Clinical Trial Update: An Evaluation of the Safety of CSF-1 in Presbyopic Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety of CSF-1 in presbyopia has completed. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Presbyopia

Drugs mentioned

• CSF-1

Snippet

Sponsor: Orasis Pharmaceuticals Ltd. | Conditions: Presbyopia | Phase 3 | Status: COMPLETED | Results posted: 2025-06-11